Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine and Zinc for COVID-19 Prevention in Military Healthcare Workers
NCT04377646Phase 3Unknown
- Sponsor
- Military Hospital of Tunis
- Start
- May 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine & Zinc, Hydroxychloroquine and Placebo (3 arms). Primary endpoint: SARS CoV2 infection at 2 months. Status: unknown.
02
Drugs
hydroxychloroquinezinc
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04377646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377646.